Jakarta, IO – When it comes to children’s health, respiratory issues are often a major source of anxiety for parents, especially since the incidence of respiratory diseases among young children remains alarmingly high. For instance, data from the Health Ministry’s (Kemenkes) 2023 Indonesian Health Survey (SKI) reveals that asthma cases among children aged four and under reached 70,771 cases.
Proper early management is crucial to prevent conditions from worsening, particularly for patients with asthma, bronchiolitis, or chronic lung diseases that require inhalation therapy. However, when a child experiences shortness of breath and needs immediate vapor therapy, traditional nebulizers often introduce new problems, ranging from noisy motors that terrify children to bulky dimensions that make them cumbersome to carry.
Addressing this reality, Omron Healthcare Indonesia today officially introduced the Nebulizer NE-U300, a device engineered to meet the exact needs of parents by being portable, lightweight, quiet, affordable, and rechargeable via a Type-C port. The launch expands Omron’s mesh nebulizer portfolio in Indonesia, complementing the premium NE-U100 line and the mid-tier NE-U200 line.
Tomoaki Watanabe, Director of Omron Healthcare Indonesia, noted that the trend of using mesh nebulizers among consumers continues to rise. However, he pointed out that not all products currently on the market deliver the expected performance, consistency, and reliability, often leading to an unsatisfactory user experience.
Watanabe stated that the Omron NE-U300 comes at a more accessible price point for the public while maintaining the high-quality standards of Omron nebulizers, which are trusted by millions worldwide. The company hopes that more families, especially dynamic young mothers, will now have access to a respiratory aid that is practical, reliable, and affordable.
Speaking to the media in Jakarta on Thursday (2/7/2026), dr. Wahyuni Indawati, Sp.A, Subsp.Respi(K), Chair of the Respirology Coordinating Working Unit of the Indonesian Pediatric Society (IDAI), emphasized that education on managing respiratory diseases must be continually strengthened, including encouraging families to correctly administer inhalation therapy at home according to doctors’ recommendations.
According to dr. Wahyuni, the success of therapy in children is determined not only by the medication given but also by their comfort during the inhalation process. “The device is quiet, easy to use, and allows therapy to be administered without increasing the child’s anxiety can significantly improve treatment compliance,” she noted.
To meet these real-world needs, the NE-U300 nebulizer is designed with a strict focus on functionality, solving the challenges that arise when children are frightened by loud machine noises or when treatments must be administered outside the home.
The NE-U300 features a built-in rechargeable battery via a USB Type-C port, eliminating the need for single-use disposable batteries. Its travel-friendly design weighs only 117 grams and features a highly compact frame, allowing the device to easily slip into a jacket pocket or bag, making it perfect for families who travel and cannot afford to skip scheduled inhalation sessions.
In terms of performance, the NE-U300 generates an average aerosol particle size of approximately 4.12 µm, which is ideal for ensuring medication effectively reaches the lower respiratory tract. It operates at an ultra-quiet noise level of ≤40 dB so children can undergo therapy comfortably and calmly, while its medication cup features a 10 mL capacity that is ample for standard prescribed dosages.
Every retail package comes fully equipped with a child mask, an adult mask, a mouthpiece, a USB Type-C cable, a soft storage pouch, a medication cup, and various supporting accessories, making it ready for immediate use at home or on the go. Furthermore, in conjunction with National Children’s Day this July, safety remains an absolute priority for little ones.
Due to their smaller body mass, children are highly vulnerable to even small doses of harmful chemicals. Omron ensures that all of its nebulizers, including the masks provided with the NE-U300, are 100 percent phthalate-free. While several other nebulizer masks on the market still utilize this chemical, Indonesian families can now breathe easy, using Omron devices without worrying about hidden health risks.
Read More: Siloam Hospitals Asri launches Comprehensive Pelvic and Bladder Clinic
The phthalate-free label guarantees that Omron products are clear of phthalates, which are synthetic chemicals commonly used in the industry as plasticizers or scent retainers. Exposure to these substances has been linked to significant health hazards, including endocrine and hormonal disruptions, reproductive health issues, complications in pregnant women, and potential long-term cancer risks. The NE-U300 ensures that every inhalation session brings pure healing to the child, without threatening their future health.
“In addition to the NE-U300, Omron previously launched the NE-U200 in May 2026. The NE-U200 is a mesh nebulizer that utilizes disposable meshes, offering enhanced hygiene since the mesh does not need to be washed after use. Furthermore, the NE-U200 accommodates 360-degree usage, allowing medication to be administered even while the patient is lying down,” said Fanny Susilowati, Marketing Manager of Omron Healthcare Indonesia.
Through the rollout of the NE-U300, Omron Healthcare Indonesia reinforces its commitment to delivering healthcare innovations tailored to the needs of the Indonesian public. With its portable design, silent operation, and charging convenience, the NE-U300 is set to help more families manage respiratory therapy comfortably, consistently, and with uncompromised quality. (est)
